Medtronic, Edwards Lifesciences Drive Percutaneous Aortic and Mitral Heart Valve Replacement and Repair Markets to over $1.2 Billion by 2017

January 18, 2011

Cardiac Surgery Market to Reach Over $4.4 Billion by 2017

VANCOUVER, Jan. 18 /PRNewswire/ – According to a new report by iData Research (www.idataresearch.net), the leading global authority in medical device and pharmaceutical
market research, percutaneous aortic valve replacement (PAVR) and
percutaneous mitral valve repair (PMVR) devices are expected to enter
the U.S. market in 2011 and grow to almost $1.3 billion by 2017.
Adoption of these devices for treating mitral regurgitation, aortic
stenosis and aortic insufficiency will fuel the overall U.S. cardiac
surgery market to over $4.4 billion by 2017.  Companies such as
Medtronic and Edwards Lifesciences are expected to be the first
suppliers of PAVR and PMVR devices for the U.S. market.

“Approximately 1.2 million people in the U.S. have malfunctioning aortic
valves and advances in diagnostic technologies, such as CT and MRI are
increasing the diagnosis rates” says Dr. Kamran Zamanian, CEO of iData.
“PAVR allows for aortic valve replacement without the need for open
surgery, increasing patient safety and reducing recovery times. However
the lack of long-term clinical data, complexity and high-cost of the
procedure may limit initial adoption.”

The report states that PAVR products by Medtronic and Edwards are
available on the market in Europe, while U.S. clinical trials are
currently underway. PMVR products by Evalve for the treatment of mitral
regurgitation are also approved in Europe and pending FDA approval.

“Mitral valve disorders are usually diagnosed in patients over 65 and
physicians are reluctant to perform open surgery if other comorbidities
exist,” says Dr. Zamanian. “PMVR procedures allow for a larger number
of patients to be treated, leading to a CAGR of over 60% by 2017.”

iData’s report series on the U.S., European and Asian “Markets for
Cardiac Surgery Devices” includes: tissue and mechanical heart valves,
annuloplasty repair, PMVR, PAVR, ONCAB, OPCAB, endoscopic
vessel-harvesting, cardiac ablation, transmyocardioal
revascularization, intra-aortic balloons, artificial hearts,
anastomosis-assist, ventricular-assist, PFO, ASD and VSD devices.

For more information, register free on iData’s website at:

About iData Research

iData Research (www.idataresearch.net/idata/discoveridata.php) is an international market research and consulting group focused on
providing market intelligence for medical device and pharmaceutical
companies. iData covers research in: cardiac surgery, interventional
cardiology, peripheral vascular, vascular-access, CRM and more.

SOURCE iData Research Inc.

Source: newswire

comments powered by Disqus